Frederick C. de Beer

10.4k citations

131 papers · 8.3k indexed · 1 hit paper · h-index 52

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes, Cardiovascular Risks, and Lipoproteins
Clinical Biochemistry top 0.5%

Papers in

Surgery 67
- Pancreatitis Pathology and Treatment 35
- Cholesterol and Lipid Metabolism 18
Endocrinology, Diabetes and Metabolism 22
- Diabetes, Cardiovascular Risks, and Lipoproteins 21

Co-authors: Nancy R. Webb Deneys R. van der Westhuyzen Mark B. Pepys Maria C. de Beer M C de Beer A F Strachan Ernst Malle D R van der Westhuyzen
Journals: Journal of Lipid Research (26 papers)Arteriosclerosis Thrombosis and Vascular Biology (14 papers)Journal of Biological Chemistry (10 papers)Biochemical Journal (10 papers)Atherosclerosis (5 papers)
Partner nations: United States United Kingdom South Africa

In The Last Decade

Frederick C. de Beer

130 papers receiving 8.0k citations

Hit Papers

align trajectories log scale

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. 1995 · 678 citations

Peers

Countries citing papers authored by Frederick C. de Beer

Since Specialization

Citations

This map shows the geographic impact of Frederick C. de Beer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick C. de Beer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick C. de Beer more than expected).

Fields of papers citing papers by Frederick C. de Beer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick C. de Beer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick C. de Beer. The network helps show where Frederick C. de Beer may publish in the future.

Co-authors

The 25 scholars most cited alongside Frederick C. de Beer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frederick C. de Beer Line = papers co-authored together Frederick C. de Beer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Antisense oligonucleotide targeting hepatic Serum Amyloid A limits the progression of angiotensin II-induced abdominal aortic aneurysm formation Atherosclerosis ·Preetha Shridas, Ailing Ji, Julie Ragatz, Victoria P. Noffsinger, Luke W. Meredith, Frederick C. de Beer, Adam E. Mullick, Nancy R. Webb, Dennis G. Karounos, Lisa R. Tannock	2024	1
2	Deficiency of Acute-Phase Serum Amyloid A Exacerbates Sepsis-Induced Mortality and Lung Injury in Mice International Journal of Molecular Sciences ·Ailing Ji, Julie Ragatz, Victoria P. Noffsinger, Luke W. Meredith, Noel-Ann Bradshaw, 杨文波, Ling Guo, Xiang‐An Li, Frederick C. de Beer, Nancy R. Webb, Lisa R. Tannock, Marlene E. Starr, Christopher M. Waters, Preetha Shridas	2023	6
3	Serum amyloid A is not incorporated into HDL during HDL biogenesis Journal of Lipid Research ·Ailing Ji, Xuebin Wang, Victoria P. Noffsinger, Adrieli Guidarini Roman, Maria C. de Beer, Frederick C. de Beer, Lisa R. Tannock, Nancy R. Webb	2020	11
4	The Impairment of Macrophage-to-Feces Reverse Cholesterol Transport during Inflammation Does Not Depend on Serum Amyloid A SHILAP Revista de lepidopterología ·Maria C. de Beer, Joanne M. Wroblewski, Victoria P. Noffsinger, Ailing Ji, Jason M. Meyer, Deneys R. van der Westhuyzen, Frederick C. de Beer, Nancy R. Webb	2013	26
5	SAA does not induce cytokine production in physiological conditions Cytokine ·Myung‐Hee Kim, Maria C. de Beer, Joanne M. Wroblewski, Nancy R. Webb, Frederick C. de Beer	2012	42
6	Nascent HDL formation by hepatocytes is reduced by the concerted action of serum amyloid A and endothelial lipase Journal of Lipid Research ·Joanne M. Wroblewski, Anisa Jahangiri, Ailing Ji, Frederick C. de Beer, Deneys R. van der Westhuyzen, Nancy R. Webb	2011	26
7	ATP binding cassette G1-dependent cholesterol efflux during inflammation Journal of Lipid Research ·Maria C. de Beer, Ailing Ji, Anisa Jahangiri, Ashley M. Vaughan, Frederick C. de Beer, Deneys R. van der Westhuyzen, Nancy R. Webb	2010	33
8	Group X secretory phospholipase A2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice Atherosclerosis ·И.В. Калюгина, Boris B. Boyanovsky, Preetha Shridas, William Bailey, Kathy Forrest, Deborah A. Howatt, Michael H. Gelb, Frederick C. de Beer, Alan Daugherty, Nancy R. Webb	2010	39
9	A Murine Model of Obesity With Accelerated Atherosclerosis Obesity ·Victoria King, David Lenart, Evgeniy Panfilov, M C de Beer, Frederick C. de Beer, Lisa R. Tannock	2009	62
10	Serum Amyloid A, but Not C-Reactive Protein, Stimulates Vascular Proteoglycan Synthesis in a Pro-Atherogenic Manner American Journal Of Pathology ·Patricia G. Wilson, Joel Thompson, Nancy R. Webb, Frederick C. de Beer, Victoria King, Lisa R. Tannock	2008	59
11	ApoA-II modulates the association of HDL with class B scavenger receptors SR-BI and CD36 Journal of Lipid Research ·Maria C. de Beer, Lawrence W. Castellani, Lei Cai, Arnold J. Stromberg, Frederick C. de Beer, Deneys R. van der Westhuyzen	2004	26
12	Overexpression of SR-BI by adenoviral vector promotes clearance of apoA-I, but not apoB, in human apoB transgenic mice Journal of Lipid Research ·Nancy R. Webb, Maria C. de Beer, Jin Yu, Mark S. Kindy, Alan Daugherty, Deneys R. van der Westhuyzen, Frederick C. de Beer	2002	37
13	The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake Journal of Lipid Research ·Nancy R. Webb, Lei Cai, S S Li, Yu Jin, Mark S. Kindy, Deneys R. van der Westhuyzen, Frederick C. de Beer	2002	37
14	Serum Protein 90K/Mac-2BP Is an Independent Predictor of Disease Severity during Hepatitis C Virus Infection Clinical Chemistry and Laboratory Medicine (CCLM) ·Peng-Bo, Jan Hofmann, M. A. C. S. Portugal, Christian Sebesta, Frederick C. de Beer, K Bauer, K. Huber	2000	28
15	Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practice European Journal of Clinical Investigation ·Ernst Malle, Frederick C. de Beer	1996	298
16	Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. Journal of Clinical Investigation ·Brian J. Van Lenten, Susan Hama, Frederick C. de Beer, Diana M. Stafforini, Thomas M. McIntyre, Stephen M. Prescott, Bert N. La Du, Alan M. Fogelman, M. Navab Hit paper breakdown →	1995	678
17	C‐reactive protein in patients undergoing cardiac surgery Anaesthesia ·H. Boralessa, Frederick C. de Beer, N.J. Stenstra, J.G. WHITWAM, Mark B. Pepys	1986	43
18	C reactive protein concentrations during long distance running. BMJ ·A F Strachan, Timothy D. Noakes, M. Lavelle, Anand Subedi, Frederick C. de Beer	1984	60
19	Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. The Journal of Experimental Medicine ·Ian Rowe, A.K. Soutar, I. Trayner, M L Baltz, Frederick C. de Beer, Lucy S. K. Walker, David E. Bowyer, J. Herbert, A. Feinstein, Mark B. Pepys	1984	38
20	Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. The Journal of Experimental Medicine ·Frederick C. de Beer, A.K. Soutar, M L Baltz, I. Trayner, A. Feinstein, Mark B. Pepys	1982	148

About Frederick C. de Beer

Frederick C. de Beer is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology and Oncology, having authored 131 papers that have together received 8.3k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (42 papers), Pancreatitis Pathology and Treatment (35 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (21 papers), Cholesterol and Lipid Metabolism (18 papers), Liver Disease Diagnosis and Treatment (17 papers), Drug Transport and Resistance Mechanisms (16 papers), Alzheimer's disease research and treatments (16 papers) and Peroxisome Proliferator-Activated Receptors (14 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Clinical Biochemistry (527 citations), Surgery (3.3k citations), Immunology (1.5k citations) and Molecular Biology (3.7k citations). Frederick C. de Beer has collaborated with scholars based in United States, United Kingdom and South Africa. Frequent co-authors include Nancy R. Webb, Deneys R. van der Westhuyzen, Mark B. Pepys, Maria C. de Beer, M C de Beer, A F Strachan, Ernst Malle, D R van der Westhuyzen, Mark S. Kindy and Lei Cai. Their work appears in journals such as Journal of Lipid Research, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Biochemical Journal and Atherosclerosis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact